Vivani Medical
VANI
58 hedge funds and large institutions have $10.9M invested in Vivani Medical in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 26 increasing their positions, 10 reducing their positions, and 8 closing their positions.
529% more call options, than puts
Call options by funds: $176K | Put options by funds: $28K
160% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 10
59% more capital invested
Capital invested by funds: $6.87M → $10.9M (+$4.05M)
0.36% more ownership
Funds ownership: 0.34% → 0.7% (+0.36%)
8% less funds holding
Funds holding: 63 → 58 (-5)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
Top Buyers
Top Sellers
VANI Hedge Fund Activity: Q1 2017 in Review
58 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q1 2017, worth a combined $10.9M — up 59% from $6.87M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of VANI and 7 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 26 added.
The largest buyer was Versant Venture Management, opening a new position worth an estimated $7.17M. The largest seller was Millennium Management, cutting an estimated $353K.
- 58 institutional investors held Vivani Medical (VANI) as of Q1 2017, down from 63 in Q4 2016.
- Funds reported $10.9M of Vivani Medical stock for Q1 2017, up 59% quarter-over-quarter.
- 7 funds opened new Vivani Medical positions in Q1 2017 and 8 closed out, a net change of -1 holder.
- The largest Vivani Medical buyer in Q1 2017 was Versant Venture Management, an estimated $7.17M added.
- The largest Vivani Medical seller in Q1 2017 was Millennium Management, an estimated $353K sold.
Based on aggregated 13F filings for Q1 2017.